• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation.

作者信息

Curtiss L K, Forte T M, Davis P A

出版信息

J Immunol. 1984 Sep;133(3):1379-84.

PMID:6430997
Abstract

Lipoproteins were isolated from adult plasma and the umbilical cord blood plasma of newborn infants and were compared for their capacity to inhibit mitogen-stimulated [3H]thymidine uptake of adult peripheral blood mononuclear cells in vitro. Relative to the comparable adult lipoproteins, cord blood low density lipoproteins and high density lipoproteins inhibited mitogen stimulation at twofold to fourfold lower total protein concentrations. Apoproteins AI, B, and E were quantitated by radioimmunoassay of each of the adult and cord blood lipoprotein fractions. A strong correlation was observed between inhibitory activity and the amount of apoprotein E in the cord blood low and high density lipoproteins. Further evidence that lipoproteins containing apoprotein E accounted for the difference in suppressive activity of cord blood low and high density lipoproteins relative to the adult lipoproteins was obtained by selective removal of the apoprotein E-containing lipoproteins by using immunoaffinity chromatography or heparin-agarose adsorption. The results indicated that cord blood lipoproteins containing apoprotein E in association with apoproteins AI or B are capable of suppressing lymphocyte proliferation in vitro.

摘要

相似文献

1
Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation.
J Immunol. 1984 Sep;133(3):1379-84.
2
Lipoproteins of the newborn rat. Reciprocal development of low density lipoproteins and apoprotein E-rich high density lipoproteins.新生大鼠的脂蛋白。低密度脂蛋白与富含载脂蛋白E的高密度脂蛋白的相互发育。
J Dev Physiol. 1988 Aug;10(4):321-34.
3
Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In.载脂蛋白E是正常免疫调节脂蛋白LDL-In的一种生物活性成分。
J Immunol. 1986 May 15;136(10):3716-23.
4
[Apoproteins in dyslipoproteinemia (author's transl)].[异常脂蛋白血症中的载脂蛋白(作者译)]
Diabete Metab. 1981 Mar;7(1):51-61.
5
Development of a lipoprotein profile using capillary electrophoresis and mass spectrometry.使用毛细管电泳和质谱法开发脂蛋白谱。
Electrophoresis. 1997 Sep;18(10):1796-806. doi: 10.1002/elps.1150181014.
6
[Apoproteins C and E from very low and high density lipoproteins in men with dysalphalipoproteinemia].
Vopr Med Khim. 1982 May-Jun;28(3):117-23.
7
Evaluation of lipids, lipoproteins and apolipoproteins concentrations in cord blood serum of newborns from rural and urban environments.农村和城市环境中新生儿脐带血血清脂质、脂蛋白和载脂蛋白浓度的评估。
Ann Agric Environ Med. 2007;14(1):25-9.
8
Lecithin:cholesterol acyltransferase, lipids and lipoproteins in maternal and umbilical cord plasma.卵磷脂:胆固醇酰基转移酶、母体和脐带血血浆中的脂质及脂蛋白
Artery. 1983;11(4):264-72.
9
Suppression of lymphocyte activation by plasma lipoproteins.血浆脂蛋白对淋巴细胞激活的抑制作用。
Cancer Res. 1983 May;43(5 Suppl):2496s-2502s.
10
Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency.患有外周动脉供血不足的男性患者的血清脂蛋白及载脂蛋白A I和A II
Acta Chir Scand. 1982;148(8):675-8.

引用本文的文献

1
Heterogeneous expression of apolipoprotein-E by human macrophages.人类巨噬细胞载脂蛋白E的异质性表达。
Immunology. 2004 Nov;113(3):338-47. doi: 10.1111/j.1365-2567.2004.01972.x.
2
Apolipoprotein E modulates immune activation by acting on the antigen-presenting cell.载脂蛋白E通过作用于抗原呈递细胞来调节免疫激活。
Immunology. 2003 Jul;109(3):392-7. doi: 10.1046/j.1365-2567.2003.01665.x.
3
Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms.γ干扰素通过翻译后机制抑制巨噬细胞载脂蛋白E的产生。
J Clin Invest. 1993 May;91(5):2031-9. doi: 10.1172/JCI116425.